Status:
UNKNOWN
Non-invasive Brain Stimulation in Huntington's Disease
Lead Sponsor:
Western University, Canada
Conditions:
Huntington Disease
Eligibility:
All Genders
15-75 years
Phase:
NA
Brief Summary
Huntington's disease is a disabling neurodegenerative disease. Patients present with involuntary movements of the body and cognitive symptoms like behavioral problem, difficulty in planning tasks, etc...
Detailed Description
The investigators have planned to study the feasibility of non-invasive brain stimulation via Transcranial pulsed current stimulation (tPCS) in patients of Huntington's disease. Anodal stimulation wil...
Eligibility Criteria
Inclusion
- Patients of Huntington's disease diagnosed clinically or genetically proved
Exclusion
- • Patients who can't walk even with support, like wheel chair bound patients.
- Patients having other issues like stroke that can aggravate speech/ gait.
- Patients who are not able to provide informed consent.
- Patients who are unable to communicate by speech and who can't comprehend the English language.
Key Trial Info
Start Date :
September 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04429230
Start Date
September 7 2021
End Date
December 31 2022
Last Update
September 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.